GENEVA, Nov. 24 -- SUZHOU ALPHAMAB CO., LTD (Building C23 Biobay 218 Xinghu St., SIPSuzhou, Jiangsu 215125), 苏州康宁杰瑞生物科技有限公司 (中国江苏省苏州市工业园区星湖街218号C23) filed a patent application (PCT/CN2025/094653) for "BLOOD COAGULATION FACTOR FXI/FXIA INHIBITOR FOR TREATING PULMONARY HYPERTENSION AND/OR HYPERTENSION" on May 13, 2025. With publication no. WO/2025/237307, the details related to the patent application was published on Nov 20, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, ...